[Stocks in Focus] Hanmi Pharm surges 8%+ on Fabry disease new drug tech export and obesity drug hopes
Predicted impact: Medium
Fabry technology export of about ₩635B already reported; this is a price move on known news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.